⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 5, 2024Frontiers in PediatricsOpen Access

Ambroxol hydrochloride spray (Luo Runchang®) in the treatment of acute respiratory infectious diseases: a prospective, multicenter, open label, randomized controlled study

Lu Cheng Min Liu Rong Wang Sufen Cao Rui Li Bo Su Hongyan Wei Haijuan Yang Lingyun Hou Cuicui Geng Yuling Han Tianrui Yang

View Full Paper

Ask AI

Bookmark

Share

Abstract

Cough and sputum are the most common clinical symptoms of acute respiratory tract infection. Ambroxol is a mucolytic expectorant commonly used in clinical practice. This study aimed to evaluate the efficacy, safety, and compliance of ambroxol hydrochloride spray (Luo Runchang ®) for the treatment of acute respiratory tract diseases in children.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cheng et al. (2024) studied this question.

synapsesocial.com/papers/68e59556b6db64358752ffc7 https://doi.org/10.3389/fped.2024.1380189

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Ambroxol for the treatment of children with acute and chronic respiratory diseases: an overview of efficacy and safetyReview · 2020 · 39 citations
2Efficacy and safety of inhaled ambroxol solution in improving sputum of lower respiratory tract infection in children: a multicenter, randomized, double-blind, placebo-controlled trial2025 · 1 citations
3Safety of ambroxol in the treatment of airway diseases in adult patientsReview · 2018 · 52 citations
4Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhoodOriginal Research · 2011 · 49 citations
5Comparative Study on the Effect of Different Modes of Administration of Ambroxol Hydrochloride in the Treatment of Pediatric Respiratory Diseases2024 · 1 citations